CDK4/6 inhibitors as adjuvant therapy in early breast cancer? Uncertain benefits, guaranteed harms. Haslam A, Ranganathan S, Prasad V, Olivier T, et al. Eur J Cancer 2024;207:114192.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Haslam A, Ranganathan S, Prasad V, Olivier T, et al. CDK4/6 inhibitors as adjuvant therapy in early breast cancer? Uncertain benefits, guaranteed harms. Eur J Cancer 2024;207:114192.
PMID: 38959677